Skip to Main Content

Paper Details

ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
ESMO Open
5
2021
Author NameAffiliation
David I QuinnUSC Norris Comprehensive Cancer Center, Keck School of Medicine
  • 1 - 1

Datasets

Release 1.2